SCHEMBL8960632

SCHEMBL8960632

CCCCCCCCCCCCCCCCCCCCCCOc1ccc(C(=O)OC)cc1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.74
TP53 P04637 1/20 0.71
TSHR P16473 1/20 0.71
PLA2G4B P0C869 5/20 0.69
RAB9A P51151 1/20 0.66
RARB P10826 3/20 0.65
NPC1 O15118 2/20 0.62
LMNA P02545 2/20 0.62
NFKB1 P19838 1/20 0.62
NFKB2 Q00653 1/20 0.62
RELA Q04206 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
MGLL Q99685 1/20 0.62
PLA2G4A P47712 1/20 0.61
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3051368 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL3055019 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL302793 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL3051371 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL12113908 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL3052051 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL302596 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL7171003 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL21908583 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A
SCHEMBL2622417 1.00 MAPT (0.74) MAPTTP53TSHRPLA2G4BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3263579-B1 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED AJINOMOTO KK (JP) 2022-11-30 EP disclosed
EP-4049991-A1 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED AJINOMOTO CO., INC. (JP) 2022-08-31 EP disclosed
CN-113717239-A Precipitation accelerator and precipitation method using the same 味之素株式会社 2021-11-30 CN disclosed
CN-107207555-B Precipitation accelerator and precipitation method using the same 味之素株式会社 2021-10-22 CN disclosed
US-10464966-B2 Precipitation promoter and precipitation method in which same is used AJINOMOTO CO., INC. (JP) 2019-11-05 US disclosed
EP-3263579-A1 PRECIPITATION ACCELERATOR AND PRECIPITATION METHOD IN WHICH SAME IS USED AJINOMOTO CO., INC. (JP) 2018-01-03 EP disclosed
US-20170320904-A1 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED AJINOMOTO CO., INC. (JP) 2017-11-09 US disclosed
EP-0689685-A1 BALLASTED LEUCO DYES AND PHOTOTHERMOGRAPHIC ELEMENT CONTAINING SAME MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-01-03 EP disclosed
US-5424183-A Stable color images, high resolution MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-06-13 US disclosed
WO-1994022055-A1 BALLASTED LEUCO DYES AND PHOTOTHERMOGRAPHIC ELEMENT CONTAINING SAME MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170320904-A1 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED SP1, MED25, CTCF MAPT 1874/4885TP53 421/4885TSHR 3627/4885
US-10464966-B2 Precipitation promoter and precipitation method in which same is used SP1, MED25, CTCF MAPT 1874/4885TP53 421/4885TSHR 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.